• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDE5 抑制剂伐地那非不影响大鼠和人类的听觉感觉门控。

The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans.

机构信息

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

出版信息

Psychopharmacology (Berl). 2013 Jan;225(2):303-12. doi: 10.1007/s00213-012-2817-7. Epub 2012 Aug 2.

DOI:10.1007/s00213-012-2817-7
PMID:22855271
Abstract

RATIONALE

Sensory gating is an adaptive mechanism of the brain to prevent overstimulation. Patients suffering from clinical disorders such as Alzheimer's disease or schizophrenia exhibit a deficit in gating, which indicates not only an impairment in basic information processing that might contribute to the cognitive problems seen in these patients. Phosphodiesterase type 5 inhibitors (PDE5-Is) have been shown to improve cognition in rodents in various behavioural tasks and might consequently be an interesting target for cognition enhancement. However, the effects of PDE5-Is on sensory gating are not known yet.

OBJECTIVES

This work aims to study the effects of PDE5 inhibition on auditory sensory gating in rats and humans.

METHODS

In the rat study, vehicle or 0.3-3 mg/kg of the PDE5-I vardenafil was given orally 30 min before testing and electrode locations were the vertex, hippocampus and the striatum. The human subjects received placebo, 10-20 mg vardenafil 85 min before testing and sensory gating was measured at the cortex (Fz, Fcz and Cz) electrodes.

RESULTS

Significant gating was only found for the N1 component in rats while all three peaks P1, N1 and P2 showed gating in humans, i.e. the response to the second sound click was decreased as compared with the first for these deflections. Administration of vardenafil did neither have an effect on sensory gating in rats nor in humans.

CONCLUSIONS

These findings imply that positive effects of PDE5 inhibition on cognition are not mediated by more early phases of information processing.

摘要

原理

感觉门控是大脑的一种自适应机制,可防止过度刺激。患有阿尔茨海默病或精神分裂症等临床疾病的患者表现出门控缺陷,这不仅表明基本信息处理受损,而这种受损可能导致这些患者出现认知问题。磷酸二酯酶 5 抑制剂(PDE5-Is)已被证明可改善各种行为任务中小鼠的认知能力,因此可能是增强认知的一个有趣目标。然而,PDE5-Is 对感觉门控的影响尚不清楚。

目的

本研究旨在研究 PDE5 抑制对大鼠和人类听觉感觉门控的影响。

方法

在大鼠研究中,在测试前 30 分钟给予载体或 0.3-3mg/kg 的 PDE5-I 伐地那非口服,电极位置为顶点、海马体和纹状体。人类受试者接受安慰剂,在测试前 85 分钟给予 10-20mg 伐地那非,在 Fz、Fcz 和 Cz 电极处测量感觉门控。

结果

在大鼠中仅发现 N1 成分有明显的门控,而在人类中,所有三个峰 P1、N1 和 P2 都显示出门控,即与第一个声音点击相比,这些波幅的第二个声音点击的反应降低。伐地那非给药既没有影响大鼠也没有影响人类的感觉门控。

结论

这些发现表明,PDE5 抑制对认知的积极影响不是通过信息处理的早期阶段介导的。

相似文献

1
The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans.PDE5 抑制剂伐地那非不影响大鼠和人类的听觉感觉门控。
Psychopharmacology (Berl). 2013 Jan;225(2):303-12. doi: 10.1007/s00213-012-2817-7. Epub 2012 Aug 2.
2
The effects of the phosphodiesterase type 5 inhibitor vardenafil on cognitive performance in healthy adults: a behavioral-electroencephalography study.5 型磷酸二酯酶抑制剂伐地那非对健康成年人认知表现的影响:一项行为-脑电图研究。
J Psychopharmacol. 2013 Jul;27(7):600-8. doi: 10.1177/0269881113477747. Epub 2013 Feb 20.
3
The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.三种磷酸二酯酶 5 抑制剂对早泄患者射精潜伏期的影响:双盲实验室研究。
BJU Int. 2011 Apr;107(8):1274-7. doi: 10.1111/j.1464-410X.2010.09646.x. Epub 2010 Sep 7.
4
Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.磷酸二酯酶5抑制剂西地那非、他达拉非和伐地那非对大鼠肛尾肌的影响:功能和生化方面
Clin Exp Pharmacol Physiol. 2009 Apr;36(4):358-66. doi: 10.1111/j.1440-1681.2008.05071.x. Epub 2008 Oct 15.
5
Chronic treatment with a PDE5 inhibitor increases contractile force of normal bladder in rats.慢性使用 PDE5 抑制剂可增加正常大鼠膀胱的收缩力。
Int Urol Nephrol. 2010 Mar;42(1):53-6. doi: 10.1007/s11255-009-9564-7. Epub 2009 May 16.
6
PDE2 and PDE10, but not PDE5, inhibition affect basic auditory information processing in rats.PDE2 和 PDE10 的抑制作用,但不是 PDE5 的抑制作用,会影响大鼠的基本听觉信息处理。
Behav Brain Res. 2013 Aug 1;250:251-6. doi: 10.1016/j.bbr.2013.05.014. Epub 2013 May 17.
7
Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.BAY 60-4552 和伐地那非联合应用对海绵体神经损伤大鼠具有促勃起作用:治疗磷酸二酯酶 5 抑制剂失败的概念验证研究。
Eur Urol. 2011 Nov;60(5):1020-6. doi: 10.1016/j.eururo.2011.07.052. Epub 2011 Jul 30.
8
Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms.磷酸二酯酶 5(PDE5)抑制可改善物体识别记忆:提示中枢和外周机制。
Neurobiol Learn Mem. 2012 May;97(4):370-9. doi: 10.1016/j.nlm.2012.02.008. Epub 2012 Mar 8.
9
Testosterone/estradiol ratio regulates NO-induced bladder relaxation and responsiveness to PDE5 inhibitors.睾酮/雌二醇比值调节一氧化氮诱导的膀胱松弛和对 PDE5 抑制剂的反应性。
J Sex Med. 2012 Dec;9(12):3028-40. doi: 10.1111/j.1743-6109.2012.02946.x. Epub 2012 Oct 11.
10
Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.BAY 60-4552 与伐地那非协同作用对勃起功能障碍患者及临床磷酸二酯酶 5 抑制剂治疗失败患者的海绵体组织舒张作用。
J Sex Med. 2013 May;10(5):1268-77. doi: 10.1111/jsm.12095. Epub 2013 Feb 19.

引用本文的文献

1
Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial.测试他达拉非的认知效应。PASTIS试验的神经心理学次要结果。
Cereb Circ Cogn Behav. 2023 Sep 26;5:100187. doi: 10.1016/j.cccb.2023.100187. eCollection 2023.
2
PDE5 inhibitor drugs for use in dementia.用于治疗痴呆症的磷酸二酯酶5抑制剂药物。
Alzheimers Dement (N Y). 2023 Sep 25;9(3):e12412. doi: 10.1002/trc2.12412. eCollection 2023 Jul-Sep.
3
Memory Enhancers for Alzheimer's Dementia: Focus on cGMP.用于阿尔茨海默病痴呆症的记忆增强剂:聚焦于环磷酸鸟苷

本文引用的文献

1
Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms.磷酸二酯酶 5(PDE5)抑制可改善物体识别记忆:提示中枢和外周机制。
Neurobiol Learn Mem. 2012 May;97(4):370-9. doi: 10.1016/j.nlm.2012.02.008. Epub 2012 Mar 8.
2
An evaluation of P50 paired-click methodologies.P50 配对比对方法的评估。
Psychophysiology. 2011 Dec;48(12):1692-700. doi: 10.1111/j.1469-8986.2011.01262.x. Epub 2011 Sep 27.
3
Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study.
Pharmaceuticals (Basel). 2021 Jan 13;14(1):61. doi: 10.3390/ph14010061.
4
Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.治疗性靶向 3',5'-环核苷酸磷酸二酯酶:抑制与超越。
Nat Rev Drug Discov. 2019 Oct;18(10):770-796. doi: 10.1038/s41573-019-0033-4. Epub 2019 Aug 6.
5
Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial.在一项随机试验中,急性给予罗氟司特可增强健康年轻人类的感觉门控作用。
Psychopharmacology (Berl). 2018 Jan;235(1):301-308. doi: 10.1007/s00213-017-4770-y. Epub 2017 Nov 3.
6
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.卡巴拉汀而非伐地那非可逆转大麻对健康人类言语记忆的损害。
Psychopharmacology (Berl). 2015 Jan;232(2):343-53. doi: 10.1007/s00213-014-3667-2. Epub 2014 Jul 8.
重复服用乌地那非(欣炜歌)对勃起功能障碍患者认知、躯体化和勃起功能的影响:一项初步研究。
Int J Impot Res. 2011 May-Jun;23(3):109-14. doi: 10.1038/ijir.2011.13. Epub 2011 May 5.
4
Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis.探究第一和第二反应对视神经阻断指数相对贡献:一项荟萃分析。
Psychophysiology. 2011 Jul;48(7):980-92. doi: 10.1111/j.1469-8986.2010.01168.x. Epub 2011 Jan 7.
5
Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.西地那非辅助利培酮治疗精神分裂症阴性症状的双盲随机安慰剂对照试验。
Psychopharmacology (Berl). 2011 Feb;213(4):809-15. doi: 10.1007/s00213-010-2044-z. Epub 2010 Oct 15.
6
The Role of Age, Gender, Education, and Intelligence in P50, N100, and P200 Auditory Sensory Gating.年龄、性别、教育程度和智力在P50、N100和P200听觉感觉门控中的作用
J Psychophysiol. 2009;23(2):52-62. doi: 10.1027/0269-8803.23.2.52.
7
Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia--gating of auditory-evoked potentials and prepulse inhibition.精神分裂症神经发育动物模型中听觉感觉加工的评估——听觉诱发电位的门控和前脉冲抑制
Behav Brain Res. 2010 Dec 1;213(2):142-7. doi: 10.1016/j.bbr.2010.04.026. Epub 2010 Apr 24.
8
Sensory processing in schizophrenia: neither simple nor intact.精神分裂症的感觉处理:既不简单也不完整。
Schizophr Bull. 2009 Nov;35(6):1059-64. doi: 10.1093/schbul/sbp110. Epub 2009 Oct 15.
9
Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients.药物治疗的精神分裂症患者中N100中潜伏期听觉诱发电位的感觉门控缺陷。
Schizophr Res. 2009 Sep;113(2-3):339-46. doi: 10.1016/j.schres.2009.05.019. Epub 2009 Jun 12.
10
Reduction of prelimbic inhibitory gating of auditory evoked potentials after fear conditioning.恐惧条件反射后前边缘区听觉诱发电位抑制性闸门的降低。
Behav Neurosci. 2009 Apr;123(2):315-27. doi: 10.1037/a0014364.